Niagen Bioscience (NAGE) Stock Price, News & Analysis

Company Overview

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Key Stats

• Today's Range: $10.38 to $10.99
• 50-Day Range: $5.42 to $10.95
• 52-Week Range: $2.31 to $10.99
• Volume: 1.05 million shs
• Average Volume: 842,541 shs
• Market Capitalization: $862.53 million
• P/E Ratio: 64.41
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NAGE Stock Analysis - Frequently Asked Questions

How have NAGE shares performed this year?

Niagen Bioscience's stock was trading at $5.48 on January 1st, 2025. Since then, NAGE shares have increased by 99.8% and is now trading at $10.95.
View the best growth stocks for 2025 here.

How do I buy shares of Niagen Bioscience?

Shares of NAGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Medicinal Chemicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:NAGE
• Previous Symbol: NASDAQ:NAGE
• CIK: 1386570
• Web: N/A
• Phone: (310) 388-6706
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 64.41
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $107.93 million
• Price / Sales: 7.99
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 78,770,000
• Free Float: N/A
• Market Cap: $862.53 million
• Optionable: N/A
• Beta: 1.94